Digestive Diseases and Sciences

, Volume 31, Issue 5, pp 524–529

Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility

  • R. S. Alphin
  • A. G. Proakis
  • C. A. Leonard
  • W. L. Smith
  • W. N. Dannenburg
  • W. J. Kinnier
  • D. N. Johnson
  • L. F. Sancilio
  • J. W. Ward
Original Articles

Abstract

The antiemetic activity, gastric motor activity, and dopamine receptor effects of metoclopramide, dazopride, and sulpiride were assessed to establish if enhancement of gastric motility or antagonism of central dopamine receptors is the predominant action for drug-induced suppression of cisplatin-induced emesis. Emesis produced in dogs by cisplatin is antagonized by metoclopramide and dazopride. The antiemetic actions of metoclopramide and dazopride are associated with their ability to enhance gastric motor activity. Dazopride, unlike metoclopramide, has minimal dopamine receptor antagonist properties. Sulpiride is a potent dopamine receptor antagonist; however, it had no effect on the stomach and was ineffective in suppressing cisplatin-induced emesis.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Plenum Publishing Corporation 1986

Authors and Affiliations

  • R. S. Alphin
    • 1
  • A. G. Proakis
    • 1
  • C. A. Leonard
    • 1
  • W. L. Smith
    • 1
  • W. N. Dannenburg
    • 1
  • W. J. Kinnier
    • 1
  • D. N. Johnson
    • 1
  • L. F. Sancilio
    • 1
  • J. W. Ward
    • 1
  1. 1.Research and Development DivisionA.H. Robins CompanyRichmond

Personalised recommendations